Lanadelumab treatment is effective and safe in patients with factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Authors
Category Primary study
Conference52nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, ADF
Year 2026
This article has no abstract
Epistemonikos ID: a42c3954c9b4ea25cdd157f283e32c6321a88453
First added on: Aug 08, 2026